Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3

Methodology|Interests|Funding|Corrections

Finding aid

Document registry — page 4

Every document the Institute has published, 1,621 in total, with its identifier, type, certainty rating and review date.

Documents

1,621 documents · page 4 of 41

Bibliographic record: Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients…

CEI-BR-103Bibliographic record2026-q3

The Lancet Diabetes & Endocrinology 2017

30 Jul 2026
Bibliographic record: RoB 2: a revised tool for assessing risk of bias in randomised trials

CEI-BR-104Bibliographic record2026-q3

BMJ 2019

30 Jul 2026
Bibliographic record: First-in-class cardiolipin-protective compound as a therapeutic agent to restore…

CEI-BR-105Bibliographic record2026-q3

British Journal of Pharmacology 2014

30 Jul 2026
Bibliographic record: Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion…

CEI-BR-106Bibliographic record2026-q3

Journal of Clinical Endocrinology & Metabolism 2006

30 Jul 2026
Bibliographic record: Compounded GLP-1 receptor agonists: safety advisory

CEI-BR-107Bibliographic record2026-q3

TGA Safety Advisory 2024

30 Jul 2026
Bibliographic record: Detecting peptidic drugs, drug candidates and analogs in sports doping: current status…

CEI-BR-108Bibliographic record2026-q3

Expert Review of Proteomics 2019

30 Jul 2026
Bibliographic record: The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1…

CEI-BR-109Bibliographic record2026-q3

Diabetes, Obesity and Metabolism 2020

30 Jul 2026
Bibliographic record: General Chapter ⟨1225⟩ Validation of Compendial Procedures

CEI-BR-110Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2024

30 Jul 2026
Bibliographic record: General Chapter ⟨795⟩ and ⟨797⟩ Pharmaceutical Compounding — Nonsterile and Sterile…

CEI-BR-111Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2023

30 Jul 2026
Bibliographic record: General Chapter ⟨71⟩ Sterility Tests

CEI-BR-112Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2024

30 Jul 2026
Bibliographic record: General Chapter ⟨788⟩ Particulate Matter in Injections

CEI-BR-113Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2024

30 Jul 2026
Bibliographic record: General Chapter ⟨85⟩ Bacterial Endotoxins Test

CEI-BR-114Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2024

30 Jul 2026
Bibliographic record: General Chapter ⟨921⟩ Water Determination

CEI-BR-115Bibliographic record2026-q3

United States Pharmacopeia — National Formulary (USP–NF) 2024

30 Jul 2026
Bibliographic record: Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral…

CEI-BR-116Bibliographic record2026-q3

JAMA 2021

30 Jul 2026
Bibliographic record: Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity…

CEI-BR-117Bibliographic record2026-q3

Nature Medicine 2023

30 Jul 2026
Bibliographic record: Protein aggregation — pathways and influencing factors

CEI-BR-118Bibliographic record2026-q3

International Journal of Pharmaceutics 2010

30 Jul 2026
Bibliographic record: Once-weekly semaglutide in adolescents with obesity

CEI-BR-119Bibliographic record2026-q3

New England Journal of Medicine 2022

30 Jul 2026
Bibliographic record: Daily oral GLP-1 receptor agonist orforglipron for adults with obesity

CEI-BR-120Bibliographic record2026-q3

New England Journal of Medicine 2023

30 Jul 2026
Bibliographic record: Medical Product Alert N°2/2024: falsified semaglutide

CEI-BR-121Bibliographic record2026-q3

WHO Medical Product Alert 2024

30 Jul 2026
Bibliographic record: WHO Expert Committee on Specifications for Pharmaceutical Preparations — Fifty-seventh…

CEI-BR-122Bibliographic record2026-q3

WHO Technical Report Series 2023

30 Jul 2026
Bibliographic record: Once-weekly semaglutide in adults with overweight or obesity

CEI-BR-123Bibliographic record2026-q3

New England Journal of Medicine 2021

30 Jul 2026
Bibliographic record: Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1…

CEI-BR-124Bibliographic record2026-q3

Diabetes, Obesity and Metabolism 2022

30 Jul 2026
Defined term: Certainty of evidence

CEI-GT-001Defined term2026-q3

The Institute’s judgement of the extent to which an effect estimate is adequate to support a conclusion. Reported at one of four levels: high, moderate, low or very low…

30 Jul 2026
Defined term: High certainty

CEI-GT-002Defined term2026-q3

The Institute is confident that the true effect lies close to the estimate. Further research is very unlikely to change confidence in the estimate. A high rating is not…

30 Jul 2026
Defined term: Moderate certainty

CEI-GT-003Defined term2026-q3

The true effect is likely to be close to the estimate, but there is a real possibility that it is substantially different. Further research is likely to have an…

30 Jul 2026
Defined term: Low certainty

CEI-GT-004Defined term2026-q3

Confidence in the effect estimate is limited and the true effect may be substantially different. The Institute states in each case whether the limitation arises from…

30 Jul 2026
Defined term: Very low certainty

CEI-GT-005Defined term2026-q3

The Institute has very little confidence in the effect estimate. In this document set a very low rating most often reflects an absence of controlled human evidence…

30 Jul 2026
Defined term: Absence of evidence

CEI-GT-006Defined term2026-q3

A state in which no study adequate to answer a question has been identified. The Institute records an absence of evidence as distinct from evidence of absence: the first…

30 Jul 2026
Defined term: Evidence of absence

CEI-GT-007Defined term2026-q3

A finding, from a study adequately powered to detect an effect of the size of interest, that no such effect was observed. A negative result from an adequately powered…

30 Jul 2026
Defined term: Downgrading

CEI-GT-008Defined term2026-q3

The reduction of a certainty rating from its starting level because of a concern in one of five domains: risk of bias, inconsistency, indirectness, imprecision and…

30 Jul 2026
Defined term: Upgrading

CEI-GT-009Defined term2026-q3

The increase of a certainty rating above its starting level, applicable in principle to observational evidence showing a large effect, a dose–response gradient or a…

30 Jul 2026
Defined term: Risk of bias

CEI-GT-010Defined term2026-q3

The extent to which features of a study’s design or conduct could produce an effect estimate that systematically departs from the truth. Assessed at the level of the…

30 Jul 2026
Defined term: Indirectness

CEI-GT-011Defined term2026-q3

A mismatch between the population, intervention, comparator or outcome of the contributing studies and those of the question being answered. Also applied where an…

30 Jul 2026
Defined term: Imprecision

CEI-GT-012Defined term2026-q3

A confidence interval wide enough that its ends would support different decisions, or an event count too small to constrain the estimate. Assessed against a decision…

30 Jul 2026
Defined term: Inconsistency

CEI-GT-013Defined term2026-q3

Unexplained variation in effect estimates across contributing studies, beyond what chance would produce. Consistency of direction with variation in magnitude is treated…

30 Jul 2026
Defined term: Publication bias

CEI-GT-014Defined term2026-q3

The risk that the studies available to a review are not a representative sample of the studies conducted, most often because studies with unfavourable results were not…

30 Jul 2026
Defined term: Selective outcome reporting

CEI-GT-015Defined term2026-q3

The reporting of a subset of measured outcomes chosen after the results were known. Detected by comparing the published report with the registered protocol, which the…

30 Jul 2026
Defined term: Summary of findings

CEI-GT-016Defined term2026-q3

A structured table presenting, for each pre-specified outcome, the number of contributing participants and studies, the absolute and relative effect, the certainty…

30 Jul 2026
Defined term: Evidence synthesis

CEI-GT-017Defined term2026-q3

A document answering a structured question by identifying, appraising and combining the studies that bear on it, according to a protocol registered before the search was…

30 Jul 2026
Defined term: Scoping review

CEI-GT-018Defined term2026-q3

A structured map of the evidence available for a question, published where the Institute judges that a quantitative synthesis is not yet supportable. A scoping review…

30 Jul 2026

page 4 of 41

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.